• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION RX/5MM BASKET DIAMETER/180CM; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION RX/5MM BASKET DIAMETER/180CM; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE Back to Search Results
Catalog Number 501814RE
Device Problem Retraction Problem (1536)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/28/2022
Event Type  malfunction  
Manufacturer Narrative
This is one of two products involved with the reported event and the associated manufacturer report number is: 1016427-2022-05422.A review of the manufacturing documentation associated with lot 35265344 presented no issues during the manufacturing process that can be related to the reported event.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, during the use of a 5mm 180cm angioguard rx embolic capture guidewire (ecgw) system, it was not possible to advance the capture system over the angioguard to recapture the device.As a result, the capture sheath could not be used, and a new 5mm 180cm angioguard rx ecgw system was opened in order to use its capture sheath to remove the first 5mm angioguard device.However, the capture sheath for the second 5mm angioguard device was also unable to advance over the first 5mm angioguard device.Therefore, a 6f non-cordis guiding catheter was used and was able to advance over the initially deployed 5mm angioguard, through a previously deployed stent to successfully recapture the distal protection of the 5mm angioguard.There was no reported injury to the patient.Both devices were inspected, stored, and prepped per the instructions for use (ifu) and there was nothing unusual about either device prior to use.The first 5mm angioguard device was deployed without issue, and there were no reported separations on either device.Information regarding the patient, target lesion characteristics, flushing of the device, and the removal of the first 5mm angioguard was requested but was not provided.The device will be returned for evaluation.
 
Manufacturer Narrative
This is one of two products involved with the reported event and the associated manufacturer report number is: 1016427-2022-05422.This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Manufacturer Narrative
This is one of two products involved with the reported event and the associated manufacturer report number is: 1016427-2022-05422.Complaint conclusion: during the use of a 5mm 180cm angioguard rx embolic capture guidewire (ecgw) system, it was not possible to advance the capture system over the angioguard to recapture the device.As a result, the capture sheath could not be used, and a new 5mm 180cm angioguard rx ecgw system was opened in order to use its capture sheath to remove the first 5mm angioguard device.However, the capture sheath for the second 5mm angioguard device was also unable to advance over the first 5mm angioguard device.Therefore, a 6f non-cordis guiding catheter was used and was able to advance over the initially deployed 5mm angioguard, through a previously deployed stent to successfully recapture the distal protection of the 5mm angioguard.There was no reported injury to the patient.Both devices were inspected, stored, and prepped per the instructions for use (ifu) and there was nothing unusual about either device prior to use.The first 5mm angioguard device was deployed without issue, and there were no reported separations on either device.Information regarding the patient, target lesion characteristics, flushing of the device, and the removal of the first 5mm angioguard was requested but was not provided.The products were returned for analysis.One non-sterile rx/5mm basket diameter/180cm unit was received coiled for analysis inside a plastic bag.Per visual analysis, the capture sheath and the ecgw were returned for evaluation.No anomalies were observed on the components during the analysis.Per functional analysis the capture sheath advanced over the ecgw returned for analysis and capture the filter basket with no difficulty or resistance/friction.A product history record (phr) review of lot 35265344 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿capture sheath ¿ resistance/friction - inner lumen¿ and ¿capture system - capture difficulty - unable to¿ were not confirmed by analysis of the returned devices as functional analysis was performed successfully.The exact cause of the reported event could not be determined.Procedural and/or handling factors might have contributed to the reported event since the device did not present any indication of manufacturing defect or anomaly that could contribute to the event as reported.According to the instructions for use, which are not intended as a mitigation of risk, ¿capture sheath ¿ after the interventional or diagnostic procedure is completed, attach a 10-ml luer lock syringe to flushing luer hub.Flush with 10 ml of sterile saline.The entire coil dispenser should be filled with saline.Remove the syringe from the flushing luer hub.Do not remove the capture sheath from the coil dispenser until required system retrieval.Note: never attempt to capture the filter basket with the deployment sheath.Once the lesion is treated and all of the interventional or diagnostic devices have been removed, remove the flushed capture sheath from the dispenser coil and thread over the proximal end of the guidewire.Grasp the guidewire proximally as it exits the rx port and push the capture sheath through the open hemostasis valve.Collapse the filter basket by advancing the capture sheath until the distal capture sheath marker band is adjacent to the proximal filter basket marker band.Using fluoroscopy, confirm filter basket closure by ensuring reduction of diameter of the radiopaque strut marker bands.Note: do not try removing the angioguard rx emboli capture guidewire by only pulling on the capture sheath.Note: never pull the angioguard rx emboli capture guidewire into the guiding catheter or interventional sheath introducer if there is resistance.If resistance is encountered, reposition the capture sheath to ensure that the filter basket is properly seated into the capture sheath.Using fluoroscopy, verify capture sheath position by checking marker band alignment between the capture sheath and the guidewire.Remove the device by grasping the guidewire and capture sheath together near the hemovalve.Pull the system through the guiding catheter or interventional sheath introducer, and out of the hemovalve as a single unit.Care should be taken when pulling the basket through the open hemovalve, to avoid potential release of captured emboli.¿ the devices performed as intended and therefore the reported event and the phr could not be related to the manufacturing process; therefore, no corrective/preventive action will be taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX/5MM BASKET DIAMETER/180CM
Type of Device
TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes NH 33014
Manufacturer Contact
karla castro
14201 nw 60 avenue
miami lakes, FL 33014
7863138372
MDR Report Key15478618
MDR Text Key301128608
Report Number1016427-2022-05423
Device Sequence Number1
Product Code NTE
UDI-Device Identifier10705032054775
UDI-Public(01)10705032054775(17)240430(10)35265344
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K062531
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 10/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2024
Device Catalogue Number501814RE
Device Lot Number35265344
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/29/2022
Initial Date FDA Received09/24/2022
Supplement Dates Manufacturer Received09/29/2022
10/24/2022
Supplement Dates FDA Received10/24/2022
10/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/24/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6F BENCHMARK GUIDING CATHETER (PENUMBRA).
-
-